Cell Therapy for Spinal Cord Injury by Neural Stem/Progenitor Cells Derived from iPS/ES Cells
โ Scribed by Osahiko Tsuji; Kyoko Miura; Kanehiro Fujiyoshi; Suketaka Momoshima; Masaya Nakamura; Hideyuki Okano
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 298 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1933-7213
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Recent studies have shown that delayed transplantation of neural stem/progenitor cells (NSPCs) into the injured spinal cord can promote functional recovery in adult rats. Preclinical studies using nonhuman primates, however, are necessary before NSPCs can be used in clinical trials to treat human pa
## Abstract Despite advances in medical and surgical care, current clinical therapies for spinal cord injury (SCI) are limited. During the last two decades, the search for new therapies has been revolutionized by the discovery of stem cells, inspiring scientists and clinicians to search for stem ce
## Abstract A reliable method to induce neural progenitor/stem cells (NPCs) into dopaminergic (DAergic) neurons has not yet been established. As well, the mechanism involved remains to be elucidated. To induce DAergic differentiation from NPCs, a cytokine mixture (CโMix) of interleukin (IL)โ1ฮฒ, ILโ
## Abstract In this study, thermoresponsive xyloglucan hydrogel scaffolds were investigated as candidates for neural tissue engineering of the spinal cord. The hydrogels were optimized to provide similar mechanical properties to that of native spinal cord, although also being functionalized through